Role of ACE Inhibitors in Chronic Kidney Disease
ACE inhibitors play a critical role in slowing the progression of chronic kidney disease (CKD) by reducing proteinuria and controlling blood pressure. The ACE Inhibitors Market benefits from the increasing global burden of CKD, particularly among diabetic patients who are at higher risk.
Early intervention with ACE inhibitors in CKD patients improves renal outcomes and reduces the need for dialysis or transplantation. This clinical advantage positions ACE inhibitors as indispensable in nephrology treatment protocols, further boosting market demand.